Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 19 Oct 2022

EGFR mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report

in Thoracic Oncology

Xiangyu Xu
Zixia Shi
Dan Fu
Depei Huang
Zheng Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.1008932

3,778 views
2 citations

Original Research

Published on 18 Oct 2022

Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis

in Thoracic Oncology

Cheng-Sen Liu
Ying-Qiu Song
Run-Ze Wang
Zheng Wang
Rong He
Ke Xu
Chen-Yu Wang
Yu Wu
Ye Wang
Xiao-fang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.991378

1,532 views
1 citation

Clinical Trial

Published on 18 Oct 2022

A phase II study of buparlisib in relapsed or refractory thymomas

in Thoracic Oncology

Mohammad I. Abu Zaid
Milan Radovich
Sandra Althouse
Hao Liu
Aaron J. Spittler
Jeffrey Solzak
Sunil Badve
Patrick J. Loehrer

Frontiers in Oncology

doi 10.3389/fonc.2022.891383

2,918 views
13 citations

Case Report

Published on 18 Oct 2022

Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy

in Thoracic Oncology

Woo Kyung Ryu
Hyungkeun Cha
Mi Hwa Park
Jung Soo Kim
Jeong-Seok Choi
Lucia Kim
Kyung-Hee Lee
Hae-Seong Nam

Frontiers in Oncology

doi 10.3389/fonc.2022.900966

3,064 views
2 citations

Case Report

Published on 18 Oct 2022

Case report: A case report and literature review about Pathological transformation of lung adenosquamous cell carcinoma

in Thoracic Oncology

Liang Ge-ge
Geng Cuicui
Li Leiqiang
Tian Yongcang
Ma Jiangang
Ou Yiwen
Sun Li-zhe

Frontiers in Oncology

doi 10.3389/fonc.2022.1029679

2,459 views
4 citations

Original Research

Published on 17 Oct 2022

Osimertinib versus platinum-pemetrexed in patients with previously treated EGFR T790M advanced non-small cell lung cancer: An updated AURA3 trial-based cost-effectiveness analysis

in Thoracic Oncology

Yin Shi
Rui Pei
Shao Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.833773

4,522 views
3 citations

Original Research

Published on 17 Oct 2022

Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices

in Thoracic Oncology

Stephen V. Liu
Xiaohan Hu
Yeran Li
Bin Zhao
Thomas Burke
Vamsidhar Velcheti

Frontiers in Oncology

doi 10.3389/fonc.2022.999343

7,442 views
22 citations

Original Research

Published on 17 Oct 2022

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment

in Thoracic Oncology

Changqing Dong
Wanwan Cheng
Meiling Zhang
Si Li
Lele Zhao
Dongsheng Chen
Yong Qin
Mingzhe Xiao
Shencun Fang

Frontiers in Oncology

doi 10.3389/fonc.2022.992596

3,446 views
3 citations

Original Research

Published on 17 Oct 2022

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma

in Thoracic Oncology

Fengling Shao
Huajie Mao
Tengling Luo
Qijun Li
Lei Xu
Yajun Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.894485

5,703 views
19 citations

Case Report

Published on 17 Oct 2022

Secondary mutant ALK-I1171s in pituitary metastases from a patient with ALK fusion-positive advanced lung adenocarcinoma: A case report and literature review

in Thoracic Oncology

Dan Han
Kewei Zhao
Qin Yang
Liling Zhang
Shihong Fei

Frontiers in Oncology

doi 10.3389/fonc.2022.1016320

2,066 views
2 citations

Case Report

Published on 17 Oct 2022

Case report: Using DNA short tandem repeats to confirm nongestational origin of pulmonary choriocarcinoma

in Thoracic Oncology

Filipa Ferreira da Silva
Rita Barata
Inês Rolim
Catarina Carvalheiro
Nuno Gil
Marcos Pantarotto

Frontiers in Oncology

doi 10.3389/fonc.2022.1001627

1,887 views
2 citations

Original Research

Published on 14 Oct 2022

Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer

in Thoracic Oncology

Liang Shi
Qiyi Meng
Li Tong
Hongxia Li
Yujie Dong
Chongyu Su
Zhe Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.956755

4,206 views
6 citations

Original Research

Published on 13 Oct 2022

AI-based chest CT semantic segmentation algorithm enables semi-automated lung cancer surgery planning by recognizing anatomical variants of pulmonary vessels

in Thoracic Oncology

Xiuyuan Chen
Hao Xu
Qingyi Qi
Chao Sun
Jian Jin
Heng Zhao
Xun Wang
Wenhan Weng
Shaodong Wang
Xizhao Sui

Frontiers in Oncology

doi 10.3389/fonc.2022.1021084

4,933 views
21 citations

Case Report

Published on 13 Oct 2022

Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation

in Thoracic Oncology

Shinkichi Takamori
Takashi Seto
Masafumi Yamaguchi
Fumihiko Kinoshita
Takatoshi Fujishita
Kensaku Ito
Ryo Toyozawa
Fumihiro Shoji
Tatsuro Okamoto

Frontiers in Oncology

doi 10.3389/fonc.2022.965741

5,111 views
12 citations

Original Research

Published on 12 Oct 2022

Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images

in Thoracic Oncology

Ri-qiang Liao
An-wei Li
Hong-hong Yan
Jun-tao Lin
Si-yang Liu
Jing-wen Wang
Jian-sheng Fang
Hong-bo Liu
Yong-he Hou
Chao Song

Frontiers in Oncology

doi 10.3389/fonc.2022.1002953

5,451 views
15 citations

Original Research

Published on 11 Oct 2022

Machine learning and BP neural network revealed abnormal B cell infiltration predicts the survival of lung cancer patients

in Thoracic Oncology

Pinghua Tu
Xinjun Li
Lingli Cao
Minghua Zhong
Zhibin Xie
Zhanling Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.882018

3,545 views
7 citations

Original Research

Published on 11 Oct 2022

Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

in Thoracic Oncology

Yaxin Chen
Lei Xia
Yuxuan Peng
Gang Wang
Liyun Bi
Xue Xiao
Cui Li
Weimin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.947808

3,391 views
2 citations

Original Research

Published on 11 Oct 2022

The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling

in Thoracic Oncology

Arivazhagan Roshini
Chandra Goparaju
Somanath Kundu
Mohan S. Nandhu
Sharon L. Longo
John A. Longo
Joan Chou
Frank A. Middleton
Harvey I. Pass
Mariano S. Viapiano

Frontiers in Oncology

doi 10.3389/fonc.2022.1014749

4,654 views
12 citations

Original Research

Published on 10 Oct 2022

MDFI is a novel biomarker for poor prognosis in LUAD

in Thoracic Oncology

Pengyu Chen
Zhen Quan
Xueyu Song
Zhaojia Gao
Kai Yuan

Frontiers in Oncology

doi 10.3389/fonc.2022.1005962

6,153 views
14 citations

Original Research

Published on 07 Oct 2022

Establishment of predictive nomogram and web-based survival risk calculator for malignant pleural mesothelioma: A SEER database analysis

in Thoracic Oncology

Sihao Chen
Wanli Yu
Shilong Shao
Jie Xiao
Hansong Bai
Yu Pu
Mengxia Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1027149

4,014 views
10 citations

Original Research

Published on 06 Oct 2022

Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy

in Thoracic Oncology

Dong Xie
Fangyi Xu
Wenchao Zhu
Cailing Pu
Shaoyu Huang
Kaihua Lou
Yan Wu
Dingpin Huang
Cong He
Hongjie Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.990608

5,771 views
26 citations

Original Research

Published on 06 Oct 2022

18F-FDG distribution pattern improves the diagnostic accuracy of single pulmonary solid nodule

in Thoracic Oncology

Nina Zhou
Annan Zhang
Hua Su
Wei Zhao
Nan Li
Zhi Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.983833

2,173 views
2 citations

Review

Published on 06 Oct 2022

Recent and current advances in PET/CT imaging in the field of predicting epidermal growth factor receptor mutations in non-small cell lung cancer

in Thoracic Oncology

Na Hu
Gang Yan
Yuhui Wu
Li Wang
Yang Wang
Yining Xiang
Pinggui Lei
Peng Luo

Frontiers in Oncology

doi 10.3389/fonc.2022.879341

3,910 views
5 citations

Original Research

Published on 06 Oct 2022

Symptoms and experiences of frailty in lung cancer patients with chemotherapy: A mixed-method approach

in Thoracic Oncology

Liran Duan
Huixia Cui
Wenlu Zhang
Shan Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.1019006

6,161 views
23 citations

1,912 articles

articles

EGFR mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report

Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis

A phase II study of buparlisib in relapsed or refractory thymomas

Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy

Case report: A case report and literature review about Pathological transformation of lung adenosquamous cell carcinoma

Osimertinib versus platinum-pemetrexed in patients with previously treated EGFR T790M advanced non-small cell lung cancer: An updated AURA3 trial-based cost-effectiveness analysis

Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: Real-world outcomes at US oncology practices

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma

Secondary mutant ALK-I1171s in pituitary metastases from a patient with ALK fusion-positive advanced lung adenocarcinoma: A case report and literature review

Case report: Using DNA short tandem repeats to confirm nongestational origin of pulmonary choriocarcinoma

Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer

AI-based chest CT semantic segmentation algorithm enables semi-automated lung cancer surgery planning by recognizing anatomical variants of pulmonary vessels

Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation

Deep learning-based growth prediction for sub-solid pulmonary nodules on CT images

Machine learning and BP neural network revealed abnormal B cell infiltration predicts the survival of lung cancer patients

Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma

The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling

MDFI is a novel biomarker for poor prognosis in LUAD

Establishment of predictive nomogram and web-based survival risk calculator for malignant pleural mesothelioma: A SEER database analysis

Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy

18F-FDG distribution pattern improves the diagnostic accuracy of single pulmonary solid nodule

Recent and current advances in PET/CT imaging in the field of predicting epidermal growth factor receptor mutations in non-small cell lung cancer

Symptoms and experiences of frailty in lung cancer patients with chemotherapy: A mixed-method approach